Polo-like kinase 1 (Plk1) regulates DNA replication origin firing and interacts with Rif1 in Xenopus

被引:13
|
作者
Ciardo, Diletta [1 ]
Haccard, Olivier [1 ]
Narassimprakash, Hemalatha [1 ]
Cornu, David [1 ]
Guerrera, Ida Chiara [2 ]
Goldar, Arach [1 ]
Marheineke, Kathrin [1 ]
机构
[1] Univ Paris Saclay, Inst Integrat Biol Cell I2BC, CNRS, CEA, F-91198 Gif Sur Yvette, France
[2] Univ Paris Struct Federat Rech Necker, Prote Platform Necker, US24, INSERM,CNRS UMS3633, F-75015 Paris, France
关键词
PROTEIN PHOSPHATASE 1; CHECKPOINT RESPONSE; BINDING DOMAIN; EGG EXTRACTS; PHOSPHORYLATION; INITIATION; COMPLEX; CHROMATIN; TRESLIN; SLD3;
D O I
10.1093/nar/gkab756
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The activation of eukaryotic DNA replication origins needs to be strictly controlled at multiple steps in order to faithfully duplicate the genome and to maintain its stability. How the checkpoint recovery and adaptation protein Polo-like kinase 1 (Plk1) regulates the firing of replication origins during non-challenged S phase remained an open question. Using DNA fiber analysis, we show that immunodepletion of Plk1 in the Xenopus in vitro system decreases replication fork density and initiation frequency. Numerical analyses suggest that Plk1 reduces the overall probability and synchrony of origin firing. We used quantitative chromatin proteomics and co-immunoprecipitations to demonstrate that Plk1 interacts with firing factors MTBP/Treslin/TopBP1 as well as with Rift, a known regulator of replication timing. Phosphopeptide analysis by LC/MS/MS shows that the C-terminal domain of Rif1, which is necessary for its repressive action on origins through protein phosphatase 1 (PP1), can be phosphorylated in vitro by Plk1 on S2058 in its PP1 binding site. The phosphomimetic 52058D mutant interrupts the Rif1-PP1 interaction and modulates DNA replication. Collectively, our study provides molecular insights into how Plk1 regulates the spatio-temporal replication program and suggests that Plk1 controls origin activation at the level of large chromatin domains in vertebrates. [GRAPHICS] .
引用
收藏
页码:9851 / 9869
页数:19
相关论文
共 50 条
  • [21] Structure based drug design and optimization of inhibitors of Polo-like Kinase 1 (PLK1)
    McBride, Christopher M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [22] Clinicopathological significance of Polo-like kinase 1 (PLK1) expression in human malignant glioma
    Cheng, Mao-Wei
    Wang, Bing-Chan
    Weng, Zhi-Qiang
    Zhu, Xiao-Wei
    ACTA HISTOCHEMICA, 2012, 114 (05) : 503 - 509
  • [23] Developments of Polo-like Kinase 1 (Plk1) Inhibitors as Anti-Cancer Agents
    Li, Shanshan
    Zhang, Yingjie
    Xu, Wenfang
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2013, 13 (14) : 2014 - 2025
  • [24] p53-dependent repression of polo-like kinase-1 (PLK1)
    McKenzie, Lynsey
    King, Sharon
    Marcar, Lynnette
    Nicol, Sam
    Dias, Sylvia S.
    Schumm, Katie
    Robertson, Pamela
    Bourdon, Jean-Christophe
    Perkins, Neil
    Fuller-Pace, Frances
    Meek, David W.
    CELL CYCLE, 2010, 9 (20) : 4200 - 4212
  • [25] Mechanisms of mammalian polo-like kinase 1 (Plk1) localization: Self-priming
    Lee, Kyung S.
    Park, Jung-Eun
    Kang, Young H.
    Zimmerman, Wendy
    Soung, Nak-Kyun
    Seong, Yeon-Sun
    Kwak, Sahng-June
    Erikson, Raymond L.
    CELL CYCLE, 2008, 7 (02) : 141 - 145
  • [26] SBE13 joins the family of Polo-like kinase 1 (Plk1) inhibitors
    Liu, Xiaoqi
    CELL CYCLE, 2010, 9 (03) : 445 - 446
  • [27] Identification of polo-like kinase 1 (PLK1) in aggressive prostate cancer by paradigm analysis
    Febbo, Phillip G.
    Goldstein, Theodore C.
    Baertsch, Robert
    Youngren, Jack
    Newton, Yulia
    Bivol, Adrian
    Small, Eric Jay
    Stuart, Joshua M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [28] Aromatic diacylhydrazine derivatives as a new class of polo-like kinase 1 (PLK1) inhibitors
    Sun, Juan
    Lv, Peng-Cheng
    Guo, Feng-Jiao
    Wang, Xin-Yi
    Xiao-Han
    Zhang, Yang
    Sheng, Gui-Hua
    Qian, Shao-Song
    Zhu, Hai-Liang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 81 : 420 - 426
  • [29] Identification of a consensus motif for Plk (Polo-like kinase) phosphorylation reveals Myt1 as a Plk1 substrate
    Nakajima, H
    Toyoshima-Morimoto, F
    Taniguchi, E
    Nishida, E
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (28) : 25277 - 25280
  • [30] MOLECULAR TARGETING OF POLO-LIKE KINASE 1 (PLK1) ELIMINATES MEDULLOBLASTOMA BRAIN TUMOUR CELLS
    Lee, Cathy
    Fotovati, Abbas
    Triscott, Joanna
    Dunn, Sandra
    NEURO-ONCOLOGY, 2012, 14 : 96 - 96